Search

You searched for "equipment"

233 results found

Trials offering cytoreductive surgery for men with de novo synchronous metastatic prostate cancer

8 November 2021 | | Basic Science Research, Urologic Oncology
Life expectancy in men diagnosed with de novo synchronous metastatic hormone-sensitive prostate cancer (mHSPC) has risen to a median of 4.8 years with upfront systemic agents (such as docetaxel) in addition to standard androgen deprivation therapy (ADT) [1-3]. Within this...

New senior appointments at The Urology Foundation

10 March 2022
New Chief Executive appointed The Urology Foundation (TUF) has appointed Rebecca Porta as Chief Executive. An established and experienced charity Chief Executive, Rebecca brings a wealth of experience having held senior roles within some of the UK’s leading health and...

In conversation with Paula Allchorne

10 March 2022
We were delighted to catch up with Paula Allchorne, Chair of the European Association of Urology Nurses (EAUN) about her career in urological nursing and her plans for the association. Can you tell us a little bit about what led...

Conservative management of pelviureteric junction

13 March 2023 | | Reconstructive Urology, Paediatric Urology
Background Pelviureteric junction obstruction (PUJO) is defined as a functionally significant impairment of urine flow from the renal pelvis into the proximal ureter. For more than a century, surgery was considered the first-choice approach to management. However, the widespread use...

Robot assisted laparoscopic prostatectomy versus open retropubic prostatectomy – complication and readmission rates

1 November 2014 | | Endourology and Stones, Urologic Oncology
Readmission rates in postoperative patients are an important health economic and clinical challenge faced in the modern NHS, with financial levies attached. In America since 2013, hospitals have been faced with ‘readmission penalties’ deducted from Medicare reimbursements. This was the...

A new haemostatic agent in tubeless PCNL

1 March 2014 | | Endourology and Stones
Tubeless percutaneous nephrolithotomy (PCNL) is increasingly being used in carefully selected patients to reduce hospital stay and analgesia requirements, especially in those with little bleeding who become stone free or have insignificant residual fragments (usually <4mm). Various agents have been...

The Urology Foundation are looking for a new chair for the Science and Education Committee

26 October 2022 | Recruitment & Personnel
An opportunity has arisen for you to bring your expertise to chair the highly regarded Science and Education Committee (SEC) of The Urology Foundation.

Surgical treatment of LUTS secondary to BPH

1 March 2017 | Functional Urology
For the vast majority of patients an initial trial of medical therapy for the management of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) is indicated [1]. In a substantial minority of cases however, a surgical intervention...

The assessment and medical treatment of LUTS secondary to BPH

1 November 2016 | Functional Urology
The term benign prostatic hyperplasia (BPH) describes prostate enlargement due to non-cancerous processes. Several aetiological mechanisms are involved, including hormonal and vascular alterations; abnormal regulation of apoptosis; and prostatic inflammation, which may stimulate cellular proliferation. With ageing, prostate enlargement can...

Surgical video – part 2: Tips on how to edit and create a finished surgical video for teaching or publication

1 November 2015 | | Technological Developments
A well-made and informative video can be one of the most valuable promotional tools for a department of urology. Having to resort to an external commercial source to produce a video can be prohibitively expensive. With the extensive computing power...

Recent developments in bladder cancer – NMIBC

3 May 2022 | | Urologic Oncology
Every year, roughly 10,300 individuals are diagnosed with bladder cancer in the UK, making it the 11th most common cancer in the UK, and the eighth most common cancer in men [1]. Of those diagnosed with the disease, 75-85% will...

Intravesical glycosaminoglycan analogue instillations for recurrent cystitis

1 May 2017 | | Infection, Functional Urology
Introduction The symptoms of recurrent cystitis can be triggered by inflammatory or infective causes. Bladder pain syndrome (BPS) and bacterial recurrent lower urinary tract infection can both present with symptoms of recurrent cystitis and cause significant morbidity in affected individuals....